HealthCare Global Enterprises Limited (NSE:HCG)
India · Delayed Price · Currency is INR 570.85
+5.30 (0.94%)
Nov 12, 2026, 3:29 PM IST
NSE:HCG Income Statement
Financials in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 30, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Operating Revenue | 27,050 | 25,384 | 22,181 | 19,079 | 16,914 | 13,948 |
Other Revenue | 72.76 | 69.76 | 47.14 | 42.48 | 30.33 | 30.05 |
| 27,123 | 25,454 | 22,229 | 19,121 | 16,944 | 13,978 | |
Revenue Growth | 12.84% | 14.51% | 16.25% | 12.85% | 21.22% | 37.92% |
Cost of Revenue | 12,842 | 11,745 | 10,319 | 8,646 | 7,747 | 6,457 |
Gross Profit | 14,281 | 13,709 | 11,910 | 10,475 | 9,198 | 7,521 |
Selling, General & Admin | 775.87 | 775.87 | 732.02 | 619.64 | 448.05 | 273.86 |
Other Operating Expenses | 8,541 | 8,213 | 7,215 | 6,553 | 5,442 | 4,869 |
Operating Expenses | 11,933 | 11,431 | 10,158 | 8,921 | 7,842 | 6,725 |
Operating Income | 2,348 | 2,278 | 1,752 | 1,555 | 1,355 | 795.46 |
Interest Expense | -1,556 | -1,664 | -1,443 | -979.33 | -904.6 | -831.05 |
Interest & Investment Income | 143.27 | 143.27 | 158.82 | 126.97 | 118.1 | 115.61 |
Earnings From Equity Investments | 24 | 14.6 | 7.71 | 3.88 | -0.18 | -14.25 |
Currency Exchange Gain (Loss) | -7.17 | -7.17 | -2.94 | 0.65 | -17.56 | -0.29 |
Other Non Operating Income (Expenses) | -7.42 | -53.32 | 68.37 | -77.2 | -95.47 | -128.67 |
EBT Excluding Unusual Items | 944.62 | 710.92 | 540.65 | 629.83 | 455.54 | -63.19 |
Merger & Restructuring Charges | - | - | - | - | - | -5.5 |
Gain (Loss) on Sale of Investments | 0.63 | 0.63 | 1.57 | 2.17 | 0.35 | 1.24 |
Gain (Loss) on Sale of Assets | 2.47 | 2.47 | -10.64 | -17.74 | -13.22 | -6.43 |
Asset Writedown | - | - | - | - | - | -467.4 |
Other Unusual Items | -560.82 | -444.92 | 38.06 | 63.03 | 6.13 | 1,419 |
Pretax Income | 386.9 | 269.1 | 569.64 | 677.29 | 448.8 | 877.72 |
Income Tax Expense | 168.47 | 41.37 | 81.3 | 263.95 | 272.5 | 488.47 |
Earnings From Continuing Operations | 218.43 | 227.73 | 488.34 | 413.34 | 176.3 | 389.25 |
Minority Interest in Earnings | -105.48 | -90.18 | -44.24 | 68.21 | 117.19 | 148.08 |
Net Income | 112.95 | 137.55 | 444.1 | 481.55 | 293.49 | 537.33 |
Net Income to Common | 112.95 | 137.55 | 444.1 | 481.55 | 293.49 | 537.33 |
Net Income Growth | -68.06% | -69.03% | -7.78% | 64.08% | -45.38% | - |
Shares Outstanding (Basic) | 146 | 141 | 140 | 139 | 139 | 130 |
Shares Outstanding (Diluted) | 147 | 143 | 142 | 140 | 140 | 135 |
Shares Change | 3.40% | 0.28% | 1.40% | 0.50% | 3.35% | 18.95% |
EPS (Basic) | 0.78 | 0.97 | 3.17 | 3.46 | 2.11 | 4.14 |
EPS (Diluted) | 0.77 | 0.96 | 3.12 | 3.43 | 2.10 | 3.97 |
EPS Growth | -69.26% | -69.23% | -9.04% | 63.33% | -47.10% | - |
Additional Metrics
Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 30, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Free Cash Flow | 298.58 | 549.88 | 1,082 | 988.99 | 1,184 | 1,489 |
Free Cash Flow Per Share | 2.04 | 3.85 | 7.60 | 7.04 | 8.47 | 11.01 |
Gross Margin | 52.65% | 53.86% | 53.58% | 54.78% | 54.28% | 53.80% |
Operating Margin | 8.66% | 8.95% | 7.88% | 8.13% | 8.00% | 5.69% |
Profit Margin | 0.42% | 0.54% | 2.00% | 2.52% | 1.73% | 3.84% |
Free Cash Flow Margin | 1.10% | 2.16% | 4.87% | 5.17% | 6.98% | 10.65% |
EBITDA | 4,130 | 3,884 | 3,102 | 2,671 | 2,372 | 1,784 |
EBITDA Margin | 15.22% | 15.26% | 13.95% | 13.97% | 14.00% | 12.76% |
D&A For EBITDA | 1,781 | 1,606 | 1,350 | 1,116 | 1,017 | 988.67 |
EBIT | 2,348 | 2,278 | 1,752 | 1,555 | 1,355 | 795.46 |
EBIT Margin | 8.66% | 8.95% | 7.88% | 8.13% | 8.00% | 5.69% |
Effective Tax Rate | 43.54% | 15.37% | 14.27% | 38.97% | 60.72% | 55.65% |
Revenue as Reported | 27,419 | 25,704 | 22,577 | 19,291 | 17,076 | 14,105 |